Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02737787
Title A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center (All Protocol Activities) Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack (All Protocol Activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (All Protocol Activities) Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (All protocol activities) Rockville Centre New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field